Domov › Trojnásobne negatívny karcinóm prsníka › New Jersey
Klinické štúdie Trojnásobne negatívny karcinóm prsníka v štáte New Jersey
20 štúdií pre Trojnásobne negatívny karcinóm prsníka hľadá účastníkov v zariadeniach v štáte New Jersey.
Mestá v štáte New Jersey
Oficiálny text štúdie (anglicky)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New Jersey, East Brunswick
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06270706A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- John Theurer Cancer Center at Hackensack UMC, Hackensack
Prebieha náborFáza 1
Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06586957Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township
Prebieha nábor
Vek 30 a viac · Ženy · Aktualizované 25. 9. 2026 · NCT02945579A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0082), Hackensack
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06841354A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06966700A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06618287A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06246968A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Hackensack Meridian Health, Hackensack
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- a 1 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT05570253Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- Regional Cancer Care Associates LLC, East Brunswick
- Hunterdon Medical Center, Flemington
- Rutgers Health, New Brunswick
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT05633654Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Summit Medical Group, Florham Park
Prebieha náborObservačná štúdia
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07211178A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Hackensack
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
Prebieha náborFáza 2
Vek 70 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT07768436A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- John Theurer Cancer Center, Hackensack
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT04895709Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT05579366A Study of LY4175408 in Participants With Advanced Cancer
- John Theurer Cancer Center At Hackensack UMC, Hackensack
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT07046923Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
- United Theranostics, Princeton
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT07311993I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 5. 2026 · NCT01042379Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 2. 2026 · NCT03808337A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 17. 2. 2026 · NCT04683679A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 6. 2025 · NCT06568692Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.